US Stock Movement: ORIC Pharmaceuticals surges on October 15 as JPMorgan raises target price and innovative oncology drugs
Bitget异动解读2026/10/15 20:00ORIC Pharmaceuticals Surge on October 15 Explained
Keywords: JPMorgan raises target price, Innovative oncology drugs
Date unspecified, JPMorgan maintains a Buy rating and raises ORIC's target price from $23 to $26.
(Disclaimer: This content is generated by AI technology based on publicly available information for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Google Android earthquake alerts extended to over 200 regions
Google launches universal shopping cart feature in the United States
Alcoa Q3 revenue reached $3.704 billions, up 24% year-on-year.
The Dow Jones rose 1.08%, the Nasdaq rose 0.08%, and the S&P 500 rose 0.33%.
Crypto prices
More
